history in patients with NTDs seen at a multidisciplinary, comprehensive outpatient clinic within a large medical center.
Methods
Our study population consisted of patients attending the multidisciplinary Spina Bifida Clinic at Children's of Alabama from June 2012 to December 2013. The patients in this clinic are between 0 and 21 years of age with a diagnosis of an NTD (e.g., spina bifida aperta, lipomeningocele, split cord, and congenital dermal sinus). The institutional review board of the University of Alabama at Birmingham provided approval prior to performing this study.
We conducted a cross-sectional survey of biological mothers of all patients attending the multidisciplinary clinic at Children's of Alabama to participate in the study on behalf of their children. We approached the qualifying families during their clinic visit, provided a letter describing the purpose and procedures of this project, and consecutively distributed a total of 254 surveys. The research staff completed the surveys while interviewing the patients' mothers in the privacy of the examination room. Data were only collected from patients who were seen in clinic with their biological mother to ensure the accuracy and reliability of the data.
During the study period, 419 patients were examined during 576 appointments in our multidisciplinary Spina Bifida Clinic. Of these patients, 254 were accompanied by their biological mother and consequently met our criteria for inclusion in our study. For the 254 eligible patients with NTDs, surveys were distributed and completed for all 254 eligible patients prior to data analysis, representing a 100% response rate. Of these, 209 patients had a diagnosis of myelomeningocele while 45 patients had a diagnosis of closed spinal dysraphism. Basic patient demographics are presented in Table 1 .
Each participating patient's mother answered questions on family history. The nonmodifiable family factors included the family history of NTDs and family history of other relevant disorders, such as other congenital CNS problems, Down syndrome, cerebral palsy, clubfoot, congenital heart defect, cleft palate, kidney malformation, cystic fibrosis, and sickle cell disease. All of the family history questions included information regarding lineage (maternal, paternal, or both) and the degree of the identified relative. Degrees of relationship were defined as previously described: first degree (parents, siblings, and children), second degree (grandparents, grandchildren, aunts, uncles, nieces, nephews, and half-siblings), or third degree (great grandparents, great grandchildren, great aunts/uncles, and first cousins). 13 All other relationships were categorized as beyond third degree. A sample patient survey is available for reference (Appendix A).
Descriptive statistics were calculated for the family history in all patients with NTDs. We then compared patients with myelomeningocele to those with closed spinal dysraphism (lipomyelomeningocele, dermal sinus tract, and split cord malformation) using the chi-square test. The chi-square statistic was used to test for statistical difference between the degrees of relatives in the family history of the NTD. The results were tabulated and analyzed using commercially available software (SPSS version 22, IBM).
Results
A total of 254 patient surveys were included in the analysis, of which 209 were from patients with myelomeningocele and 45 were from patients with closed spinal dysraphism. The overall prevalence of family history of NTDs was 16.9% (n = 43). Approximately 3.1% (n = 8) of the patients had first-degree relatives with NTD, 2.4% (n = 6) had second-degree relatives with NTD, 3.1% (n = 8) had third-degree relatives with NTD, and 8.3% (n = 21) had beyond third-degree relatives with NTD (Table 2 ). In the myelomeningocele population (n = 209), the prevalence of a positive family history was 17.7% (n = 37) versus 13.3% (n = 6) in the closed dysraphism group (p = 0.642). Of the myelomeningocele patients, 3.8% (n = 8), 2.4% (n = 5), 3.3% (n = 7), and 8.1% (n = 17) had first-, second-, third-, and beyond third-degree relatives with NTDs, respectively (Table 2) . Family history in the paternal lineage was 8.7% (n = 22) versus 10.6% (n = 27) maternal lineage in all patients. In the myelomeningocele group, 9.1% (n = 19) had a positive family history in their paternal lineage versus 11.0% (n = 23) maternal ( Table 2 ). The trend toward maternal lineage was not significant for all patients or the myelomeningocele subgroup (p = 0.751 and p = 0.453, respectively).
The overall prevalence of family history of other congenital CNS disorders was 8.7% (n = 22). For the 2 subgroups, myelomeningocele and closed spinal dysraphism, the prevalence was 9.6% (n = 20) and 4.4% (n = 2), respectively. Other congenital anomalies found in family members of myelomeningocele and closed spinal dysraphism patients, respectively, are as follows: 6.2% (n = 13) and 0% (n = 0) of patients had a family history of clubfoot; 5.7% (n = 12) and 0% (n = 0) of patients, cerebral palsy; 6.2% (n = 13) and 4.4% (n = 2) of patients, Down syndrome; 5.7% (n = 12) and 4.4% (n = 2) of patients, cardiac defect; 5.7% (n = 12) and 2.2% (n = 1) of patients, cleft lip or palate; 1.4% (n = 3) and 4.4% (n = 2) of patients, kidney malformation; 1.0% (n = 2) and 0% of patients, cystic fibrosis; and 0.5% (n = 1) and 0% of patients had a family history of sickle cell anemia (Table 3 ). There was no statistically significant difference between the subgroups (i.e., myelomeningocele and closed spinal dysraphism) for a family history of any of these conditions (Table 3) .
Patients were also surveyed on other known risk factors for the development of NTDs. The prevalence of selected risk factors is reported in Table 4 .
Discussion
While the prevalence of NTDs has declined since the advent of widespread folic acid fortification in the 1990s, NTD remains the most common and devastating congenital abnormality. 3 There are multiple known risk factors for NTDs, but genetic factors such as inheritance patterns remain largely unexplored. A few of the known risk factors include obesity, folate status, diabetes, and anticonvulsant drug use. 11, 15, 21 Previous literature regarding the family history of NTDs is reviewed in Table 5 
Family History of Spina Bifida, Central Nervous System Disorders, and Lineage
The important finding of our study is the overall high prevalence of family history of NTDs (16.9%) and other congenital CNS disorders (8.7%) in children with NTDs. Subgroup analysis of myelomeningocele and closed dysraphisms did not show a significant difference between these groups. These findings support a complex role of genetics in the development of NTDs.
Previous reports have suggested that once a mother has a child with an NTD, the risks of NTD in subsequent pregnancies are significantly higher than the reported population risks. 23 Furthermore, the risk of NTD in a subsequent pregnancy quadruples after a second NTD child is born in a given family. 30 Several other authors have described the familial aggregation of congenital CNS malformations 23 Although our percentages of family history of NTDs and CNS abnormalities in spina bifida children are higher, the aforementioned authors' estimations primarily reflect pre-folate fortification era. The associated risk from folate deficiency may have been minimized in the postfortification era, which may emphasize the role of other risk factors such as genetics and epigenetics and may explain the higher prevalence of positive history in our sample. This phenomenon could also apply to other risk factors (e.g., poverty, environmental toxins, or drug use) in the postfortification era. Additionally, it is possible that regional and geographic differences play a role in the increased prevalence observed in our sample.
In our study, there was no statistically significant difference in maternal or paternal lineages for the family history of NTDs in both myelomeningocele and closed dysraphism groups. This is consistent with prior findings 28 and argues against female-dependent inheritance (X-linked recessive or mitochondrial inheritance) and an excess of female carriers, which has been proposed. 8 Our results do not suggest simple mode of genetic transference involved in NTD development.
Family History of Other Associated Diseases
Our study demonstrated prevalence of a family history of Down syndrome in 5.9% of NTD patients compared with 1 in 691 babies born each year in the US. 22 This increased prevalence in our population suggests a common causative mechanism for both pathologies. There is some evidence that mothers of infants with Down syndrome have mutation of the methylenetetrahydrofolate reductase (MTHFR) gene involved in folic acid and methionine metabolism, which is also well established in NTDs. 12 Barkai et al. also provide support for this link between Down syndrome and NTDs. 2 Our results show a high prevalence of a family history of nonneural midline defects in our myelomeningocele population. Approximately 5.7% have a family history of cardiac or conotruncal defects, and 5.7% show a family history of cleft lip or palate. Each of these are higher than the reported US prevalence, which is less than 1% for both. 5, 6, 27 These results are consistent with the theory that birth defects resulting from fusion failure of the embryo's midline have a common etiology.
9,24,25 Previous studies support this theory, with the finding that infants with a midline defect often have more than 1 defect. 9, 24 Additionally, familial clustering of midline defects has been reported, 17, 18, 26 which also supports a role of genetics in NTDs.
Overall Findings
Epigenetics has been identified in regulating gene expression, which may play a role in the susceptibility to developing an NTD. 10, 19 The findings in our study suggest a complex genetic relationship with the development of NTDs that may reflect the role of epigenetics in this phenomenon. Our study supports previous claims that defining epigenetic mechanisms and gene profiling will help identify parents at increased risk.
Limitations
Our study has several limitations. First, we collected the data for the study through a retrospective survey, which introduces selection and recall bias into the results. The selection bias inherent in our study design is referral bias. Participants who volunteered to complete our survey may differ from the general population with NTDs, in particular, those with milder forms of NTDs, those who do not have shunt-treated hydrocephalus, and parents who chose elective termination of pregnancy.
There is also an informational or recall bias inherent in survey-based research. Consequently, the family history of NTDs may have been under-or overreported. We attempted to minimize this by ensuring only the biological mother completed the survey and by having medically trained personnel available to define terms in the survey and answer questions; however, this remains an important source of potential bias. Despite these limitations, surveys are useful because the phenomena of NTDs and its risk factors are not directly observed.
We did not survey for all possible risk factors, including socioeconomic status, environmental exposures, hot tub use, drug abuse, and excess vitamin A or tea use. We chose not to collect these data, as this is a descriptive study and is not designed to account for potential confounders; however, it is possible these factors played a role. It was not feasible with our study design to evaluate corresponding incidences of positive family history in pregnancies with a normal outcome. Including a comparison group of unaffected pregnancies would allow for these additional analyses, and this additional knowledge may be valuable and should be considered when designing future studies.
Conclusions
NTDs remain one of the most frequent and devastating congenital anomalies, and the etiology is complex. The results of our study show a high prevalence (16.9%) of a family history among NTD patients. In an environment in which optimal folic acid intake is common, our results suggest that genetics and epigenetics may play a larger role in the pathogenesis of NTD.
